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Abstract
Purpose Multifocal intraocular lenses (MIOLs) are often discouraged in patients with or at risk of retinal disorders (including diabetic
retinopathy, age-related macular degeneration, and epiretinal membranes), as MIOLs are believed to reduce contrast sensitivity (CS).
Concerns with MIOLs have also been raised in individuals with visual field defects, fixation instability or eccentric preferred retinal
locations. The aim of this study is to review the influence of MIOL on quality of vision in patients with retinal diseases.
Methods We reviewed the PubMed and Web of Science databases to identify relevant studies using the following keywords:
multifocal intraocular lens, cataract surgery, cataract extraction, lens exchange, diabetic retinopathy, age-related macular degen-
eration, and contrast sensitivity.
Results Studies evaluating CS in MIOLs present conflicting results: MIOLs either did not influence CS or resulted in worse perfor-
mance under low-illuminance conditions and higher spatial frequencies when compared to monofocal IOLs. Nevertheless, MIOLs
preserved CS levels within the age-matched normal range. Two studies reported that patients with concurrent retinal diseases receiving
aMIOL, both unilaterally and bilaterally, reported a significant improvement in visual-related outcomes. Individuals with a monofocal
IOL in one eye and a MIOL in the fellow eye reported greater subjective satisfaction with the MIOL.
Conclusion We were unable to find evidence suggesting that patients with retinal diseases should be advised against MIOLs.
Nevertheless, more research is needed to address the aforementioned concerns and to optimize the use of MIOLs in eyes with retinal
disease.
Keywords Age-relatedmaculardegeneration .Cataractsurgery .Contrastsensitivity .Diabeticretinopathy .Multifocal intraocular
lens . Refractive lens exchange
Introduction
Advances in cataract surgery and refractive lens exchange have
enabled these techniques to be used to achieve precise and de-
sired refractive outcomes[1]. This has raised patients’ expecta-
tions of excellent uncorrected distance visual acuity[2]. However,
with monofocal intraocular lenses (IOLs), the desire for freedom
from spectacles cannot be completely met. Multifocal intraocular
lenses (MIOLs) are used more commonly and to a considerable
extent for refractive purposes in non-cataractous eyes [3]. It is
believed that as MIOLs decrease contrast sensitivity, so they are
advised against in patients with retinal disorders.
MIOLs utilize diffractive or refractive optics in order to pro-
duce two or more foci. A diffractive MIOL generates
multifocality based on light interference. It incorporates a pattern
consisting of a series of annular concentric grooves less than
1 micron in depth, which are engraved around the optical axis
on either the front or the back surface of a lens (the echelette
technology). With the refractive design, multifocality is achieved
with light refraction on the MIOL surfaces based on Snell’s law.
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The performance of refractive design MIOLs depends on pupil
size and MIOL centration.
The increasing popularity of MIOLs underlines the impor-
tance of reviewing scientific evidence regarding their suitabil-
ity in patients with ocular comorbidities to aid preoperative
assessment and proper patient selection in MIOL candidates.
The aim of this study is to review the influence of MIOL on
quality of vision in patients with retinal diseases.
Materials and methods
The PubMed and Web of Science databases were the main
resources used to investigate the medical literature. An exten-
sive search was performed to identify relevant articles
concerning “multifocal intraocular lenses” and “retinal dis-
eases” up to June 30, 2018 (Appendix 1). The following key-
words were used in various combinations: multifocal intraoc-
ular lens, cataract surgery, cataract extraction, lens exchange,
diabetic retinopathy, age-related macular degeneration, and
contrast sensitivity. The search identified 247 unique articles.
Of the studies retrieved by this method, we reviewed all pub-
lications in English and abstracts of non-English publications.
The reference lists of the articles analyzed were also consid-
ered as a potential source of information. We attempted to
present all publications that employed MIOLs for patients
with retinal diseases. Studies were critically reviewed to create
an overview and guidance for further research. No attempts
were made to discover unpublished data. In addition to the
PubMed and Web of Science searches, selected chapters from
relevant textbooks were included.
Results
Contrast sensitivity (CS) and age
Various procedures and systems are employed to evaluate con-
trast sensitivity. The results of these evaluations be affected by
differences in methodology, including light conditions, speed of
performing the test, or decision-making criteria. In 1978, Arden
and Jacobson claimed that contrast sensitivity is independent of
age, and since then, several studies have sought an association
between contrast sensitivity and age [4]. Studies analyzing the
relationship between CS and age are presented in Table 1. It
might be concluded that contrast sensitivity decreases with age
and that the greatest decrease is observed at higher spatial fre-
quencies. Age and cataract are independently associated with
this decline, and posterior subcapsular cataract affects CS in
the highest degree. Lower CS was also reported in females and
in Chinese, when compared to other races present in Singapore
[5, 6]. Moreover, CS at higher spatial frequencies is lower in
myopes compared to emmetropes [5].
Burton et al. [12] suggested that optical rather than neural
changes in the visual system contribute to loss of spatial contrast
sensitivity at a photopic level in the elderly. This small loss in CS
was presumably due to interaction of a laser speckle effect and
increased light scattering in the aged eye. On the other hand,
Elliot et al. [27] reported that the decrease in contrast sensitivity
is due to neural loss. In their study, senile miosis and reduced
optical transmission, which are believed to influence CS, were
mimicked in younger subjects by reducing retinal illumination
and did not result in a decrease in CS. Higgins et al. [17] believe
that the high-spatial frequency decline in CS, although it is com-
paratively small, is too large to be due to changes in lens density
related to age. This was confirmed by Owsley et al. [23], who
demonstrated that after cataract surgery, elderly patients still have
decreased CS at higher frequencies, although they have a crys-
talline IOL. The decline in visual performance might also be due
to spatial integration and difficulty in processing visual informa-
tion in the presence of noise [28]. Morrison and Jay [29] con-
firmed with laser interferometry that the optical functions with
aging remain unchanged, while neural function significantly
declines.
CS and MIOLs
Studies analyzing CS in MIOLs present conflicting results, as
seen in Table 2. Comparing CS outcomes is difficult due to the
differences in the tests used and different illumination levels and
inconsistencies in the variables reported. Onemight conclude that
CS with MIOLs was lower than with monofocal IOLs in at least
some conditions; in some studies,MIOLs performedworse under
low-illuminance conditions and at higher spatial frequencies. The
outcome regarding CS might depend on the MIOL model and
design: diffractive optics influence CS to a lesser degree [30].
However, the quality of evidence is poor. Furthermore, none of
the studies presented an association between CS and the quality
of vision [31]. CS improved with time and achieved an age
normal range of 3–12 months after surgery. Similar results were
presented in the meta-analysis by Rosen et al. [32] and in the
review by Wang et al. [33]. Thus, doubts remain as to which
MIOL designwould offer the best visual performance and patient
satisfaction in patients with retinal disease.
Discussion
Contraindications for MIOLs
Several doubts and contraindications forMIOL implantation cur-
rently exist. These include corneal aberrations, particularly coma
or cone, whichmight result in a decreased contrast sensitivity and
dysphotopsia. IOL decentration relative to the pupil center leads
to an increase in high-order aberrations and diminished objective
contrast discrimination. Thus, an asymmetric capsulorrhexis,
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Table 1 Studies analyzing the relationship between contrast sensitivity and age in a general population
Study Subjects (age) Parameter analyzed Results
Karatepe et al.
2017 [7]
37 individuals (aged 7–65 years) CS at 0.5, 1.5, 3.0,
6.0, 12.0, and 24.0 cpd at
illumination levels
of 0–30 dB (dB)
Increasing age, small pupil diameter, hyperopia,
and photopic conditions were associated with
lower contrast sensitivity in healthy individuals
Sia et al. 2013
[8]
472 adults aged 35–80 years CS at 3, 6, 12, and 18 cpd CS decreases with age at all spatial frequencies
and is greatest at highest spatial frequencies.
Posterior subcapsular cataract causes reduction
at all frequencies, while cortical cataract does
not. Nuclear cataract decrease CS at




61 subjects (categorized in age groups
< 30 years, 30–39 years, 40–49 years,
50–59 years, > 60 years)
CS at 1.5, 3, 6, 12, and 18 cpd, under
day (85 cd/m2) and night
(3.0 cd/m2) conditions, with and
without glare
Contrast sensitivity was significantly reduced
under night conditions with glare, whereas
glare had less influence under daylight
illumination. Regression
analyses showed a highly significant influence of
age, but the variance of the measurement values
is not explained by age alone
Nomura et al.
2003 [10]
2267 subjects (aged 40–79 years) CS at 1.5, 3, 6, 12, and 18 cpd The age-related decrease in CS was found at all
frequencies, even when adjusted for visual
acuity
Nio et al. 2000
[11]
100 subjects (20–69 years of age CS at 1, 2, 4, 8, and 16 cpd; pupil
size 2, 4, and 6 mm; defocus −1 to
+2 D
At optimal focus, integrated contrast sensitivity
and log CS at 8 cpd showed a significant
age-related decline. The log CS at 1 cpd was
independent of age
Klein et al. 1996
[6]
5926 individuals (43–84 years of age) CS measured with a perimeter in the
25° central field
Visual sensitivity was inversely associated with




35 young (aged 17–29 years) and 29
older (aged 60–80 years) subjects
CS at 2, 4, 8, 12, 16, 20, 24, 28, and
32 cpd
Older adults in good eye health exhibited on
average a small loss (0.1–0.2 log unit) in




19 individuals (aged 24–63 years) CS at 1.5, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15,
20, 30, 40, 50, 60, and 70 cpd
Losses at high spatial frequencies up to 40 years
of age. After 40 years of age, there were losses




63 adults (13–67 years of age) CS at spatial frequencies of 0.5, 1, 2,
3, 4, 6, 8, and 12 cpd and temporal
frequencies of 0, 1, 5, and 15 Hz
Sensitivity for low spatial frequencies modulated
at 0 to 15 Hz was not affected by age, but a
progressive age-related elevation of threshold




8 young (average age 20.4 years) and 8
elderly (average age 64.4 years)
subjects
CS (central an 10 deg temporally) at
0.2, 0.8, 2.0, and 5.0 cpd
Young observers had better contrast sensitivities
than older observers but




12 young (19–35 years) and 11 older
(68–89 years) subjects
CS as a function of target luminance
at 0.5, 2, 4, and 8 cpd
When gratings were flickered at 0.5 Hz, functions
for older adults were displaced downward on
the sensitivity axis across all luminance levels,
and the slopes of these functions were steeper
than those for younger adults, suggesting that
optical mechanisms alone cannot account for
the vision loss in older adults.
Higgins et al.
1988 [17]
50 subjects in five age groups (20–29,
30–39, 40–49, 50–59, 60–69 years)
CS at nine spatial frequencies from
0.75 to 16 cpd
Decline in sensitivity with age at all spatial
frequencies
Elliot 1987 [18] 16 young (mean age 21.5 ± 2.7 years)
and 16 older (mean age 72 ± 4.3 years)
subjects
CS at 1, 2, 4, 10.6, and 16.5 cpd Lower contrast sensitivity at medium (4 cpd) and
high (10.6, 16.5 cpd) spatial frequencies in
older group
Yates et al. 1987
[19]
103 adults (21–40 years of age) CS at 1, 2, 4, 8, 12, 16, 20, and
24 cpd
The age-related decrease in CS was found only at
16 cpd
Graefes Arch Clin Exp Ophthalmol (2020) 258:805–813 807
haptics deformation, or finally IOL subluxation might disqualify
a patient from an MIOL. As the IOL pseudoexfoliation syn-
drome is correlated with zonular instability, centration in these
patients is questionable. Patients with a large pupil, postoperative
ametropia, and astigmatism or who have developed posterior
capsule opacification are at risk of dissatisfaction after MIOL
implantation [59, 60]. Multifocals are strictly disadvised in reti-
nitis pigmentosa and Stargardt’s disease, while diabetic retinop-
athy, age-related macular degeneration, and epiretinal mem-
branes are relative contraindications [61]. In light of this, a
thoughtful approach would be recommended in patients with
neuro-ophthalmological conditions (e.g., strabismus, Horner’s
syndrome) or glaucomatous visual field defects [62, 63].
Evidence on MIOLs and retinal diseases
Only two studies assessed the visual outcome of MIOLs in pa-
tients with concurrent retinal diseases (Table 3). Kamath et al.
[64] reported that patients with concurrent eye diseases including
age-related macular degeneration, glaucoma, or diabetic
retinopathy benefited from the multifocality of an IOL. The
MIOL arm of the study comprised 81 eyes (70 patients) and
the monofocal arm 52 eyes (41 patients). Distance visual acuities
were similar in the monofocal IOL and MIOL groups, while
uncorrected near visual acuity (UNVA) was significantly better
in the MIOL group. Patients who had a monofocal IOL in one
eye and aMIOL (Array, Abbott Medical Optics Santa Ana, CA)
in the fellow eye reported greater subjective satisfaction with the
MIOL; however, 3 of these 11 patients had more advanced pa-
thology in the eye with the monofocal IOL, making it difficult to
interpret the significance of this finding. However, no clear def-
inition of “more advanced pathology” was given by the authors.
Our study demonstrated that the results are divergent, even when
they only include normal eyes without concurrent retinal dis-
eases. Nevertheless, one might question whether the presence
of eye diseases should be a decisive reason to categorically ad-
vise against MIOLs.
Gayton et al. [65] proposed implantation of Acrysof Restor
(Alcon, Fort Worth, TX) targeting − 2.0D in eyes with age-
related macular degeneration and corrected distance visual
Table 1 (continued)
Study Subjects (age) Parameter analyzed Results
Ross et al. 1985
[20]
17 young (aged 20–30 years) and 53
older (aged 50–87 years) subjects
CS at 0.4, 0.95, 2.88, 6.73, 12.70,
and 19.23 cpd
Lower performance in older group compared to
younger group at all spatial frequencies In the
older group, linear decline in CS with age for




45 observers (including 4 elderly) CS 8–40 cpd (10–15 different
frequencies within this range)
With increasing age, CS remained steady until the
sixth decade when they declined
Kline et al. 1983
[22]
16 young (18–25 years) and 16 old
(55–70 years) subjects
CS at 0.5, 2, 4, 6, 8, and 12 cpd An age-related loss in contrast sensitivity was
observed primarily for stimuli of intermediate
and high spatial frequency
Owsley et al.
1983 [23]
91 adults aged 19–87 years CS at 0.5, 1, 2, 4, 8, and 16 cpd At higher spatial frequencies. Sensitivity




66 subjects (5–94 years old) CS at 1, 2, 3, 5, 10, 20, and 25 cpd With advancing age, there was an overall decrease
in contrast sensitivity. The loss of CS was
greater for middle range spatial frequencies
than for higher spatial frequencies
Sekuler et al.
1980 [25]
25 young (mean age 18.5 ± 0.7 years)
and 10 old (73.2 + 3.8 years)
individuals
CS at 0.5, 1, 2, 4, 8, and 16 cps
flickered at 0.3 or 6 Hz
Older and younger observers did not differ in
ability to see targets with fine structure (high
spatial frequencies); older observers were only
one-third as sensitive to targets with coarse
structure (low spatial frequencies) as were
younger observers. Older observers were also




10 children (aged 6–10 years), 12 adults
(aged 20–40 years), 5 adults (aged
40–60 years), 11 adults (aged 60 years
or older)
CS at 0.5, 1.0, 2.0, 4.0, 10, 20, and
40 cpd
No significant difference between young- and
middle-aged subjects with regard to contrast
sensitivity. For higher ages studied (above
60 years), there was a loss of sensitivity in the




50 healthy adults aged 17–64 years, 7
eyes with ocular hypertension, 43 eyes
with glaucoma
CS at 0.4, 0.8, 1.6, 3.2, and 6.4 cpd The variation in the test results with age in
normals is only slight.
cpd cycles per degree, CS contrast sensitivity
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Table 2 Contrast sensitivity in multifocal intraocular lenses




Tecnis ZCB00 (AMO, n = 44) vs. Tecnis
ZMB00 (AMO, n = 78)
CS at 3, 6, 12, and 18 cpd (mesopic
and photopic)
No difference in CS
Menucci et al.
2018 [35]
PanOptix IQ (Alcon, n = 40), AT LISA tri
839MP (Carl ZeissMeditec, n = 40), Tecnis
Symfony (AMO, n = 40)
CS at 1.5, 3, 6, 12, and 18 cpd
(mesopic and photopic)
The Tecnis Symfony MIOLs provided
significantly better photopic and mesopic
CS outcomes than the other MIOL models
Dyrda et al. 2018
[36]
OptiVis (Aaren Scientific, n = 64) vs. AR40E
(AMO, n = 64) vs. M-Flex (Rayner, n = 64)
vs. ReZoom (AMO, n = 64) vs. ReSTOR
(Alcon, n = 64)
CS at 1.5, 3, 6, 12, and 18 cpd Only under mesopic conditions without glare,
distance CS with the MIOL was
significantly lower than with the monofocal
IOL at any tested frequencies
Pedrotti et al.
2018 [30]
Tecnis (AMO, n = 30), vs. Tecnis Symfony
(AMO, n = 55), vs. ReSTOR +2.5 (Alcon,
n = 50), vs. ReSTOR +3.0 (Alcon, n = 50)
CS at 6, 12, and 18 cpd (85 cd/m2
at 4 m)
No differences in photopic CS between the
monofocal IOL and the EDOF Tecnis
Symfony in any spatial frequency. In
contrast, all contrast sensitivity values for
these two lenses were significantly better
than those obtained with both apodized
diffractive refractive ReSTOR MIOLs
Pedrotti et al.
2018 [37]
Comfort LS-313 MF 15 (Lentis, n = 11) vs.
monofocal Tecnis (AMO, n = 12)
CS at 3, 6, 12, and 18 cpd no differences in CS
Maxwell et al.
2017 [38]
Monofocal Acrysof SN60WF (Alcon) vs.
Acrysof IQ Restor +2.5
CS at 3, 6, 12, and 18 cpd
(photopic); mesopic 1.5, 3.0, 6.0,
and 12.0 cpd with and without
glare
No relevant differences in binocular CS under





AT LISA tri 839MP (Carl Zeiss Meditec,
n = 30), FineVision (Physiol, n = 30),
MPlus-LS313 (Lentis, n = 30), AcriLisa
366D (Carl Zeiss Meditec, n = 30),
ReSTOP SN6AD1 (Alcon, n = 30),
monofocal spherical Acri.Smart 48S (Carl
Zeiss Meditec, n = 30)
CS at 1.5, 3, 6, 12, and 18 cpd in
low mesopic levels
No differences in CS in low mesopic
conditions at 1.5, 3, 6, and 12 cpd but only
at 18 cpd. In pair comparison found better




multifocal Isert PY60MV (Hoya, n = 37) vs.
monovision SN60WF (Alcon, n = 38)
CS with Pelli-Robson chart No differences in CS
Gil et al. 2014
[41]
Acrysof ReSTOR SN6AD1 (Alcon, n = 35)
vs. Acrysof ReSTOR SN60D3 (Alcon,
n = 36) vs. Tecnis ZMA00 (AMO, n = 38)
vs. ReZoom NXG (AMO, n = 33) vs.
Tecnis ZA9003 (AMO, n = 38)
distance CS at 3, 6, 12, and 18 cpd
(8 levels of contrast), near CS at
1.5, 3, 6, 12, and 18 cpd (8 levels
of contrast)
Monofocal better at all spatial frequencies.
Diffractive optics and aspheric profiles
showed a non-statistically significant trend
to perform better in mesopic conditions.
Near CS was lower for refractive, distance
dominant lens designs, particularly at
medium to high spatial frequencies
Tan et al. 2014
[42]
Akreos AO (Bausch & Lomb) vs. ZMA00
(AMO) vs. Tetraflex (Lenstec) (total
n = 128 eyes)
CS visual acuity was measured at
contrast levels: 100%, 25%,
10%, and 5%
No significant differences of the CS visual
acuity were present among the three groups
at 3 months after surgery
Yamauchi et al.
2013 [43]
Tecnis ZA9003/ZCB00 (AMO) vs.
ZMA00/ZMB00 (AMO)
CS with optotype size 0.7, 1, 1.6,
2.5, 4, and 6.3 degree with and
without glare
CS (with and without glare) was better in the
monofocal group
Ji et al. 2013 [44] monofocal Acrysof Natural (Alcon, n = 27) vs.
Acrysof ReSTOR (Alcon, n = 24)
CS at 0.7, 1.0, 1.6, 2.5, 4.0, and
6.3 cpd; scotopic (80 cd/m2) and
mesopic (5 cd/m2) conditions




Tecnis ZM900 (AMO, n = 106) vs.
monovision Akreos AO (Bausch & Lomb,
n = 105)
CS with Pelli-Robson chart Monovision better than multifocal (p = 0.009)
Zhao et al. 2010
[46]
Acrysof ReSTOR SA60D3 (Alcon, n = 72) vs.
Acrysof SA60AT (Alcon, n = 89)




Tecnis Z9000 (AMO, n = 48) vs. Tecnis
ZM900 (AMO, n = 52) vs. ReZoom (AMO,
n = 64) vs. TwinSet (AcriTec, n = 64)
CS at 1.5, 3, 6, 12, and 18 cpd in
mesopic and scotopic conditions,
with and without glare
Mean contrast sensitivity was better for the
monofocal IOL group than for the MIOLs.
Patients assigned to TwinSet had less
favorable contrast sensitivity scores
compared to newer design multifocals
Cillino et al.
2008 [48]
CS at 1.5, 3, 6, 12, and 18 cpd All groups behaved similarly. At 3 cpd, the
monofocal IOL (AR40) and diffractive
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acuity (CDVA) of 20/50 or worse. This approach is particu-
larly interesting as it provided an uncorrected near + 5.2D
addition. The CDVA improved in 14 out of 20 eyes (70%)
and the UNVA in 18 out of 20 (90%) eyes. Particularly for
patients receiving MIOLs, evaluation of vision-related quality
of life shoud be considered [66]. Within this study patients
Table 2 (continued)
Study IOLs (number of eyes) Parameter analyzed Results
AR40 (AMO, n = 15) vs. Array SA40N
(AMO, n = 16) vs. ReZoom (AMO, n = 15)
vs. ZM900 (n = 16)
pupil-independent MIOL (ZM900) groups
exhibited a higher sensitivity than the
refractive MIOL groups (ReZoom and
ZM900) (P = 0.038)
Harman et al.
2008 [49]
1CU (n = 28) vs. Array SA40N (AMO,
n = 27) vs. Clariflex (AMO, n = 27)
CS with Pelli-Robson chart CS slightly higher in 1CU than in array at
3 months, No differences at 18 months
Zeng et al. 2007
[50]
Z9001 (AMO, n = 40) vs. SA60AT (Alcon,
n = 45) vs. SA40N (AMO, n = 39)
CS at 6, 12, and 18 cpd (85 cd/m2
at 4 m) with and without glare
Z9001 showed better CS than SA40AT, while
SA60AT better than SA40N (significant at
all spatial frequencies)
Sen et al. 2004
[51]
SI-40NB (AMO, n = 67) vs. Array SA-40 N
(AMO, n = 53)
CS at 1.5, 3, 6, 12, and 18 cpd CS was slightly lower with MIOLs at all
spatial frequencies; the difference was not




SI-40NB (AMO, n = 32) vs. Array SA-40 N
(AMO, n = 32)
CS at 1.5, 3, 6, 12, and 18 cpd As low luminances, distance CS for MIOL
worse than monofocal IOL for highest
spatial frequencies (12 and 18 cpd). Under




S140 N (AMO) vs. Array SA40NB (AMO)
vs. TrueVista 68STUV (Storz)
CS with Pelli-Robson chart at 1 m Mean binocular contrast
sensitivity was 1.74 (SD 0.15) for the
monofocal IOL, 1.67 (0.13) for the
multifocal, and 1.65 (0.20) for the bifocal
(unclear in statistically significant)
Kamlesh et al.
2001 [54]
Progres 3 (Domilens, n = 20) vs. Flex 65
(Domilens, n = 20)
CS with Pelli-Robson chart at
90 cd/m2
Mean CS was lower in patients with MIOLs
than those with a monofocal IOL (1.38 vs.
1.56 log units; p < 0.001)
Haaskjold et al.
1998 [55]
Diffractive bifocal PMMA 808X (Pharmacia,
n = 115) vs. monofocal 808D (Pharmacia,
n = 106)
CS at 1.5, 3, 6, 12, and 18 cpd at
distance and near
Bifocal had lower CS than monofocal IOL at
all spatial frequencies
Allen et al. 1996
[56]
Diffractive bifocal PMMA 808X (Pharmacia,
n = 79) vs. monofocal 808D (Pharmacia,
n = 70)
CS at 1.5, 3, 6, 12, and 18 cpd at
three light levels
Differences in CS at all light levels.
Particularly in medium light, bifocal group
had reduced CS compared with monofocal
IOL but still within normal limits
Percival et al.
1993 [57]
PC25 (AMO, n = 25) vs. Array (AMO, n = 25) Regan system Slightly lower CS in MIOLs than monofocal




PC-25NB (AMO, n = 30) vs. Array
MPC-25NB (AMO, n = 32)
Regan system MIOLworse than monofocal IOL only at 11%
contrast level
CS contrast sensitivity, IOL intraocular lens, MIOL multifocal intraocular lens
Table 3 Studies assessed visual outcomes of MIOL implantation in patients with concurrent retinal diseases
Study IOL Diseases Conclusion
Gayton et al. [63] Acrysof Restor
targeting −2.0D (Alcon)
Dry age-related macular degeneration
or macular degeneration associated
with disciform scarring.
In cataractous eyes with age-related macular
degeneration, replacing the crystalline lens
with this myopia-targeted multifocal
intraocular lens improved or maintained
near vision without severely compromising
distance vision





The IOLs presented similar distance visual
outcomes; however, a proportion of patients
benefited from the IOLs’ multifocality
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reported a significant improvement in visual-related items of
the 25-item Visual Function Questionnaire (VFQ-25) in both
unilateral and bilateral MIOL groups. It was concluded that
such an approach provided an improvement in near vision that
is not available with standard cataract surgery.
Uncertainty about the future
Progression of a macular disease after cataract and refractive
lens exchange is a problematic issue [59], as patients might
develop macular diseases years after the primary surgery.
Thus, it might be questioned whether a MIOL should be
disadvised in a diabetic patient who is at risk of developing
macular edema or should we advise against MIOLs only in
patients with a present macular edema or in all diabetics?
There is no evidence that MIOLs should be disadvised in these
patients.
One doubt that remains is what levels of CS should be
considered as normal, given its large standard deviation in
healthy subjects? Whether MIOL should be compared with
age-matched phakic or pseudophakic monofocal IOL sub-
jects? What level of reduction in CS should be considered as
clinically significant? And finally, what is the threshold in CS
to contraindicate MIOLs?
Conclusions
We were unable to find evidence suggesting that patients with
macular diseases should be advised against MIOLs. Several con-
traindications for MIOLs in patients with retinal diseases have a
hypothetical character and are not evidence-based.More research
is needed especially to address the effect ofMIOLs on CS, visual
functions, and patient activities such as orientation, mobility, and
reading in various retinal pathologies.
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